cp wire

CP Wire Articles

Bio-Path Doses First Patient in Ph II Expansion Trial in Acute Myeloid Leukemia

  • The primary objective of the study is to determine whether the combination of prexigebersen and LDAC provides greater efficacy than would be expected with LDAC alone... read more

Mon, 08/27/18 - 09:49 am
Magnolia Neurosciences Receives $20 Million CPRIT Grant to Develop Therapies to Treat Chemotherapy-Induced Neurological Conditions


Magnolia Neurosciences Corporation (Magnolia) announced on 8/27/18 that Korysso Therapeutics, Inc. (DBA: Magnolia Tejas Corporation), the company’s wholly owned, Houston-based subsidiary, has... read more

Mon, 08/27/18 - 09:22 am
LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis

LifeMax Laboratories, Inc. (“LifeMax”) announced on 8/27/18 an exclusive worldwide license from Novartis Pharma AG for the right to develop, manufacture and commercialize BPR277, a clinical stage... read more

Mon, 08/27/18 - 09:12 am
Adverum Biotechnologies Receives Orphan Drug Designation for Hereditary Angioedema Gene Therapy Candidate

Adverum Biotechnologies, Inc. (Nasdaq: ADVM) announced on 8/24/18 that the United States (U.S.) Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ADVM-053, a... read more

Fri, 08/24/18 - 09:50 am
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
  • Liver cancer is the second leading cause of cancer-related deaths
  • Treatment options for this type of liver cancer are limited
  • Lenvima is also approved in the US as first-... read more
Thu, 08/23/18 - 10:09 am

Pages